Home > Compound List > Product Information
Amcinonide_Molecular_structure_CAS_51022-69-6)
Click picture or here to close

Amcinonide

Catalog No. DB00288 Name DrugBank
CAS Number 51022-69-6 Website http://www.ualberta.ca/
M. F. C28H35FO7 Telephone (780) 492-3111
M. W. 502.5717032 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 173

SYNONYMS

IUPAC name
2-[(1'S,2'S,4'R,8'S,9'S,11'S,12'R,13'S)-12'-fluoro-11'-hydroxy-9',13'-dimethyl-16'-oxo-5',7'-dioxaspiro[cyclopentane-1,6'-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane]-14',17'-dien-8'-yl]-2-oxoethyl acetate
IUPAC Traditional name
cyclocort
Brand Name
Cyclocort

DATABASE IDS

CAS Number 51022-69-6
PubChem CID 443958
PubChem SID 46506705

PROPERTIES

Hydrophobicity(logP) 2.3

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Amcinonide is a corticosteroid. [Wikipedia]
Indication For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Pharmacology Amcinonide is a topical corticosteroid. The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. Amcinonide reduces or inhibits the actions of chemicals in the body that cause inflammation, redness, and swelling. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man. When in an ointment form, amcinonide also helps the skin maintain moisture.
Toxicity Results from acute toxicity studies do not indicate that any risk of acute intoxication is to be expected following a single dermal application of an overdose (application over a large area under conditions favorable to absorption) or inadvertent oral ingestion.
Affected Organisms
Humans and other mammals
Biotransformation Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys.
Absorption Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase percutaneous absorption.
Elimination Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys.
Some of the topical corticosteroids and their metabolites are also excreted into the bile.
External Links
Wikipedia
RxList
PDRhealth
Drugs.com

REFERENCES